AttayaSuvannasankhaMD

Clinical Trials

• Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma Start of enrollment: 2005 Jun 01

  Terminated

  Phase 2

• Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2007 Oct 01

  Completed

  Phase 2

• Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma Start of enrollment: 2010 Aug 27

  Completed

  Phase 1, Phase 2

• Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy Start of enrollment: 2013 Sep 01

  Terminated

  Phase 2

• Role of Osteocytes in Myeloma Bone Disease Start of enrollment: 2014 Oct 07

  Completed

• A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma Start of enrollment: 2014 Oct 01

  Withdrawn

  Phase 2

• Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy Start of enrollment: 2021 Dec 06

  Withdrawn

  Phase 2

• Phase 1/2 Study of REGN5458 in Adult Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2019 Jan 23

  Recruiting

  Phase 1, Phase 2

  Roles: Contact

• Join now to see all